SEC Form 4 · accession 0001209191-18-038054
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mitchell H. Finer
Director
Period of report
May 31, 2018
Accepted (ET)
Jun 15, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.25 | May 31, 2018 | A | 35,000 | A | — | May 30, 2028 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The shares subject to the option will vest on the one-year anniversary of May 31, 2018.